Icon

RENAGEL (nda020926)- (403MG)

SEVELAMER HYDROCHLORIDE GENZYME
403MG
No No
2014-Sep-16 Expired
None None
None No
Renagel Capsules are indicated for the reduction of serum phosphorus in patients with end-stage renal disease (ESRD).
0 0 0
Total Other Developers None
Drugs with Suitability No
403MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.